secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2023-07-06T23:59:59+00:00
Accession:  0001140361-23-033456
Event type: debt
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Strata Skin Sciences completes $15M debt refinancing with MidCap; adds $7M new tranche, option for $5M more in 2024
--------------------------------------------------------------------------------

- Refinanced existing $8M term loan and drew $7M new tranche on June 30, 2023 from MidCap Financial.
- Total debt facility $20M with an additional $5M tranche available upon meeting revenue condition in 2024.
- Interest rate: Adjusted Term SOFR plus 7.50% (floor 3.50%); interest-only through June 2026, maturity June 1, 2028.
- Amended warrant: 800,000 shares at $0.88 exercise price, exercisable until June 2033; shares to be registered.
- Company increased cash to ~$10M, strengthening balance sheet and avoiding near-term equity raise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123033456/0001140361-23-033456-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123033456/brhc20055586_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-033456

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer